Seres Therapeutics Inc (MCRB) Q3 2020 Earnings Call Transcript
MCRB earnings call for the period ending September 30, 2020.
Seres Therapeutics(MCRB)
Nasdaq Global Select
MCRB
$18.98
$0.20
1.0%
Price as of February 26, 2021, 4:36 p.m. EST
View Interactive MCRB Charts
Seres Therapeutics, Inc.
Interactive Chart
News & Analysis: Seres Therapeutics
Why Seres Therapeutics Stock Surged Today
A major investor boosted its stake in the microbiome therapeutics leader.
Why Seres Therapeutics Stock Skyrocketed 350% Today
The company's new drug could be a game changer.
Seres Therapeutics Inc (MCRB) Q1 2020 Earnings Call Transcript
MCRB earnings call for the period ending March 31, 2020.
Seres Therapeutics Inc (MCRB) Q4 2019 Earnings Call Transcript
MCRB earnings call for the period ending December 31, 2019.
Seres Therapeutics Inc (MCRB) Q3 2019 Earnings Call Transcript
MCRB earnings call for the period ending September 30, 2019.
Will the Gut Microbiome Change Medicine? Wall Street Isn't Convinced.
The potential is significant. Unfortunately, so is the hype.
Seres Therapeutics Inc (MCRB) Q2 2019 Earnings Call Transcript
MCRB earnings call for the period ending June 30, 2019.
Here's Why Seres Therapeutics Stock Soared Today
A new collaboration with AstraZeneca could give microbiome-based medicine a big lift.
Seres Therapeutics Inc (MCRB) Q4 2018 Earnings Conference Call Transcript
MCRB earnings call for the period ending December 31, 2018.
